πŸ‡ΊπŸ‡Έ FDA
Patent

US 9649373

Neoseptins: small molecule adjuvants

granted A61KA61K31/166A61K39/39

Quick answer

US patent 9649373 (Neoseptins: small molecule adjuvants) held by The Board of Regents of the University of Texas System expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/166, A61K39/39, A61K45/06, A61P